Compare Apple Inc (AAPL) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Apple Inc vs Zimmer Biomet Holdings Inc — how do they compare? Apple Inc trades at $302.27 (market cap $4.45T), while Zimmer Biomet Holdings Inc trades at $97.03 (market cap $18.55B). The key difference: Apple Inc is far larger — about 239.9× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (0.99%). Which is the better fit depends on your goals.
| AAPL | ZBH | |
|---|---|---|
Market Cap | $4.45T | $18.55B |
Volume | 100,358,844 | — |
Sector | Technology | Health |
52-Week High | $340.08 | $107.71 |
52-Week Low | $224.90 | $79.58 |
Enterprise Value | $4.47T | $25.61B |
Dividend Yield | 0.35% | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Apple (AAPL) trades at $304.91, down 1.09% with a bearish technical signal. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $2.02 vs. $1.89, and 2025 revenue reaching $416.16B. Analyst consensus is bullish with a $337.63 price target, though recent news highlights union tensions and potential Q3 earnings pressure from weaker iPhone sales.
Outlook remains positive given Apple's massive AI user base and consistent earnings beats, but risks include retail challenges, regulatory scrutiny from EU fines, and competitive pressures. The stock offers growth potential with a 27.84% ROE, though current valuation metrics suggest premium pricing.
Zimmer Biomet (ZBH) trades at $97.9, up 0.12% on the day, with a bullish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, supported by hips, specialty businesses, and technology. Key financials show a P/E of 23.6 and net income margin of 9.48%, while cash flow from operations improved to $1.70B in 2025.
The outlook is positive, with a consensus price target of $103.56 offering ~6% upside. Risks include competitive pressures and margin volatility, but consistent earnings beats and institutional accumulation support a constructive view for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Apple Inc
Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.
Read more on AAPL →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
